PASWNasdaqApparel & Other Finishd Prods of Fabrics & Similar Matl
Ping An Biomedical Co., Ltd.
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 30, 2026
$0.13+0.01 (+8.07%)
Close on Oct 19, 2026
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Ping An Biomedical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Ping An Biomedical filed with the SEC
PING AN BIOMEDICAL CO., LTD
EX-99.1 to Form 6-K
PRESS RELEASE, DATED JULY 22, 2026
EX-99.1 to Form 6-K
PING AN SALE AND PURCHASE DEED
EX-99.1 to Form 6-K
NOTICE AND PROXY STATEMENT OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
EX-99.1 to Form 6-K
EX-99.2 to Form 6-K
EX-99.2 to Form 6-K
FORM OF THE SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION
EX-99.3 to Form 6-K
Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter
EX-99.1 to Form 6-K
INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
EX-99.1 to Form 6-K
Majestic Ideal Holdings Ltd Announces Approval of Name Change to “Ping
EX-99.1 to Form 6-K
FORM OF PROXY CARD OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
EX-99.2 to Form 6-K
Statement of Policy Concerning Trading in Company
EX-99.5 to Form 6-K
PRESS RELEASE, DATED JULY 17, 2025
EX-99.6 to Form 6-K
PRESS RELEASE, DATED JULY 22, 2025
EX-99.7 to Form 6-K